The Drug Allergy History Tool, which relies on patient symptom reporting, has strong reliability when compared with EHR drug allergy information.

Almost half of US households report difficulty affording health care and the prevalence of difficulty is increasing.

Treatments for COPD, psoriasis, and neuroendocrine tumors, as well as a next-generation COVID-19 vaccine are under review.

Adalimumab had superior efficacy and safety outcomes compared with secukinumab and bimekizumab for the treatment of hidradenitis suppurativa.

There is higher risk for cardiovascular complications during delivery in pregnant patients with psoriasis compared with patients without psoriasis.

Tralokinumab use in patients with head and neck atopic dermatitis was associated with sustained improvements with up to 4 years of treatment.

An increased risk of both invasive and superficial fungal infections was observed among patients who received TNF-α inhibitors for various conditions.

In racially and socioeconomically marginalized pediatric patients there are significant inequities in the incidence of HER behavioral flags.

The CDC has released additional vaccination advice for travelers to Texas and Kansas recommending early MMR doses for children.

Delgocitinib cream is efficacious and well-tolerated for the treatment of adults with chronic hand eczema for up to 52 weeks.

Degenerative disc disease is common among young adults with PsA, with key risk factors including older age, male sex, diabetes, and inflammatory back pain.

Mohs surgery vs conventional excision was associated with decreased rates of reconstruction with positive margins for hand and foot melanoma.